Manufacturer record
Torrent Pharmaceuticals Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Torrent Pharmaceuticals Ltd (Madhya Pradesh) were declared Not of Standard Quality between May 2020 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Torrent Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Trypsin-Chymotrypsin Tablets | 2KU6M021Mfg 2025-05 · Exp 2028-04 | The sample does not conform to Manufacturer's specification with respect to Assay of Trypsin-Chymotrypsin activity.Assay | CDL KolkataCDSCO lab | Jun 2026 |
| Trypsin-Chymortypsin Tablets | 2KU6L012Mfg 2024-02 · Exp 2027-01 | Enzymatic Activity (Trypsin & Chymotrypsin) and Disintegration (Acid stage)Disintegration | Food & Drugs Laboratory, VadodaraState lab | Nov 2025 |
| Ahaglow Face Wash Gel 50 gm | AHA202Mfg 2024-05 · Exp 2026-04 | The sample does not conform to Cosmetics Rules 2020 for the standards of cosmetics. It fails the test for the content of ?Mercury? in finished cosmetic products as specified in the Laboratory Protocol.Other | DTL ThiruvananthapuramState lab | Apr 2025 |
| Chymnetra-Forte (Trypsin- Chymotrypsin Tablets) | TTP-22017Mfg 2022-02 · Exp 2025-01 | Disintegration time and AssayAssay | CDTL MumbaiCDSCO lab | Jan 2023 |
| Calcigard -10 (Nifedipine Capsules IP) | S175E004Mfg 2018-06 · Exp 2020-05 | DissolutionDissolution | CDL KolkataCDSCO lab | May 2020 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| Trypsin-Chymotrypsin Tablets | 2KU6L055 | FDAL Maharashtra | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Jan 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.